Oladepo D K, Idigbe E O, Audu R A, Inyang U S, Imade G E, Philip A O, Okafor G O, Olaleye D, Mohammed S B, Odunukwe N N, Harry T O, Edyong-Ekpa M, Idoko J, Musa A Z, Adedeji A, Nasidi A, Ya'aba Y, Ibrahim K
National Institute for Pharmaceutical Research and Development, Garki, Abuja, Nigeria.
Clin Vaccine Immunol. 2009 Sep;16(9):1374-7. doi: 10.1128/CVI.00378-08. Epub 2009 Jul 29.
A total of 2,570 apparently healthy human immunodeficiency virus-negative adults from the six geopolitical zones in the country were enrolled in our study in 2006. The samples were assayed using the Cyflow technique. Data were analyzed using the Statistical Package for Social Scientists (SPSS). The majority (64%) of the participants had CD4 counts within the range of 501 to 1,000 cells/microl. The reference range for CD4 was 365 to 1,571 cells/microl, while the reference range for CD8 was 145 to 884 cells/microl.
2006年,来自该国六个地理政治区域的总计2570名表面健康的人类免疫缺陷病毒阴性成年人参与了我们的研究。使用Cyflow技术对样本进行检测。数据采用社会科学统计软件包(SPSS)进行分析。大多数(64%)参与者的CD4细胞计数在每微升501至1000个细胞的范围内。CD4的参考范围是每微升365至1571个细胞,而CD8的参考范围是每微升145至884个细胞。